218 related articles for article (PubMed ID: 22226817)
1. A portrait of Transforming Growth Factor β superfamily signalling: Background matters.
Horbelt D; Denkis A; Knaus P
Int J Biochem Cell Biol; 2012 Mar; 44(3):469-74. PubMed ID: 22226817
[TBL] [Abstract][Full Text] [Related]
2. Cardiac pathologies in relation to Smad-dependent pathways.
Yuan SM; Jing H
Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):455-60. PubMed ID: 20650957
[TBL] [Abstract][Full Text] [Related]
3. Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands.
Mazerbourg S; Hsueh AJ
Hum Reprod Update; 2006; 12(4):373-83. PubMed ID: 16603567
[TBL] [Abstract][Full Text] [Related]
4. The transforming growth factor-beta/bone morphogenetic protein signalling pathway in adipogenesis.
Margoni A; Fotis L; Papavassiliou AG
Int J Biochem Cell Biol; 2012 Mar; 44(3):475-9. PubMed ID: 22226816
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.
He S; Liu X; Yang Y; Huang W; Xu S; Yang S; Zhang X; Roberts MS
Br J Dermatol; 2010 Mar; 162(3):538-46. PubMed ID: 19772524
[TBL] [Abstract][Full Text] [Related]
6. TGF-β/TGF-β receptor system and its role in physiological and pathological conditions.
Santibañez JF; Quintanilla M; Bernabeu C
Clin Sci (Lond); 2011 Sep; 121(6):233-51. PubMed ID: 21615335
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein receptor signal transduction in human disease.
Gomez-Puerto MC; Iyengar PV; García de Vinuesa A; Ten Dijke P; Sanchez-Duffhues G
J Pathol; 2019 Jan; 247(1):9-20. PubMed ID: 30246251
[TBL] [Abstract][Full Text] [Related]
8. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1.
Kretzschmar M; Doody J; Massagué J
Nature; 1997 Oct; 389(6651):618-22. PubMed ID: 9335504
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
10. Divergence and convergence of TGF-beta/BMP signaling.
Miyazono K; Kusanagi K; Inoue H
J Cell Physiol; 2001 Jun; 187(3):265-76. PubMed ID: 11319750
[TBL] [Abstract][Full Text] [Related]
11. A road map toward defining the role of Smad signaling in hematopoietic stem cells.
Utsugisawa T; Moody JL; Aspling M; Nilsson E; Carlsson L; Karlsson S
Stem Cells; 2006 Apr; 24(4):1128-36. PubMed ID: 16357343
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterisation of a second structurally unusual AR-Smad without an MH1 domain and a Smad4 orthologue from Echinococcus multilocularis.
Zavala-Góngora R; Derrer B; Gelmedin V; Knaus P; Brehm K
Int J Parasitol; 2008 Feb; 38(2):161-76. PubMed ID: 17845804
[TBL] [Abstract][Full Text] [Related]
13. Recent development in pleiotropic effects of statins on cardiovascular disease through regulation of transforming growth factor-beta superfamily.
Ma S; Ma CC
Cytokine Growth Factor Rev; 2011 Jun; 22(3):167-75. PubMed ID: 21700485
[TBL] [Abstract][Full Text] [Related]
14. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein.
Lee KS; Hong SH; Bae SC
Oncogene; 2002 Oct; 21(47):7156-63. PubMed ID: 12370805
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation.
Izzi L; Attisano L
Oncogene; 2004 Mar; 23(11):2071-8. PubMed ID: 15021894
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation.
Gilchrist RB; Ritter LJ; Myllymaa S; Kaivo-Oja N; Dragovic RA; Hickey TE; Ritvos O; Mottershead DG
J Cell Sci; 2006 Sep; 119(Pt 18):3811-21. PubMed ID: 16926195
[TBL] [Abstract][Full Text] [Related]
17. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility.
Schmierer B; Hill CS
Nat Rev Mol Cell Biol; 2007 Dec; 8(12):970-82. PubMed ID: 18000526
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes.
Herpin A; Cunningham C
FEBS J; 2007 Jun; 274(12):2977-85. PubMed ID: 17521337
[TBL] [Abstract][Full Text] [Related]
19. Homomeric and heteromeric complexes among TGF-β and BMP receptors and their roles in signaling.
Ehrlich M; Horbelt D; Marom B; Knaus P; Henis YI
Cell Signal; 2011 Sep; 23(9):1424-32. PubMed ID: 21515362
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.
Javelaud D; Mauviel A
Oncogene; 2005 Aug; 24(37):5742-50. PubMed ID: 16123807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
